Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...

Amid steep cuts to US foreign assistance, the Trump administration is touting a new plan to provide a powerful HIV-prevention ...

About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...

Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...

To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.

WASHINGTON - An AIDS-free generation: It seems an audacious goal, considering how the HIV epidemic still is raging around the world. Yet more than 20,000 international HIV researchers and activists ...

There were intriguing new theories and more grim statistics, puzzling observations and enlightening discoveries. “Never before in the history of medicine has so much been learned about an entirely new ...

Researchers at the pharmaceutical maker Merck & Co. Inc. announced yesterday that one of their experimental AIDS vaccines is able to protect monkeys from progressing to the damaging stage of the ...

Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own.

WASHINGTON — An AIDS-free generation: It seems an audacious goal, considering how the HIV epidemic still is raging around the world. Yet more than 20,000 international HIV researchers and activists ...